|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 11-18 | Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH | CI |
| 06/05/24 | Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Market Cap | 519K 456K 426K 391K 731K 49.71M 749K 5.05M 1.97M 24.6M 1.95M 1.91M 85.04M | P/E 2022 |
-0.11x | P/E 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 22.05M 19.37M 18.08M 16.6M 31.07M 2.11B 31.83M 214M 83.86M 1.05B 82.78M 80.98M 3.61B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.87% | +4.04% | +58.60% | +163.92% | 1,079B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 640B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -1.33% | +3.12% | +38.83% | +33.19% | 353B | |
| -0.97% | +1.44% | +36.29% | +42.20% | 301B | |
| -1.44% | +3.01% | +13.67% | +16.84% | 271B | |
| -0.64% | +5.17% | +3.65% | -38.32% | 228B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 209B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 165B | |
| Average | -0.66% | +4.83% | +32.29% | +53.47% | 412.19B | |
| Weighted average by Cap. | -0.62% | +4.86% | +41.90% | +78.32% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.43M 1.33M 1.22M 2.29M 156M 2.35M 15.82M 6.19M 77.12M 6.11M 5.98M 267M | 2.38M 2.1M 1.96M 1.8M 3.36M 228M 3.44M 23.2M 9.07M 113M 8.95M 8.76M 391M |
| Net income | -9.14M -8.03M -7.5M -6.88M -12.88M -876M -13.2M -88.92M -34.77M -433M -34.33M -33.58M -1.5B | -8.02M -7.04M -6.57M -6.03M -11.29M -768M -11.57M -77.96M -30.49M -380M -30.09M -29.44M -1.31B |
| Net Debt | 17.85M 15.69M 14.64M 13.44M 25.16M 1.71B 25.78M 174M 67.91M 846M 67.03M 65.58M 2.93B | 21.53M 18.92M 17.66M 16.21M 30.34M 2.06B 31.08M 209M 81.89M 1.02B 80.83M 79.08M 3.53B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
